FOLFOXIRI plus Bevacizumab for Metastatic Colorectal CancerByChiara Cremolini, MDFebruary 5th 2015Chiara Cremolini, MD, discusses the phase III TRIBE trial, which compared FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as for patients with metastatic colorectal cancer.